Charles Winans, M.D.
| Appointed: |
2002 |
| Gender: |
Male |
| Languages: |
English
French |
Hepato-pancreato-biliary and Transplant Surgery
General Surgery
Transplantation Center
Biographical Sketch
Charles G. Winans, MD, is a Staff Surgeon at Cleveland Clinic. His treatment interests include general surgery, abdominal solid organ transplantation (liver, pancreas, kidney) and hepatobiliary surgery--as well as treatment of carcinoid syndrome and abdominal soft tissue sarcomas. He is
board-certified in general surgery.
Education & Fellowships
| Medical School: | Yale University School of Medicine, New Haven, CT |
|
| Internship: | University of Chicago Hospitals, General Surgery, Chicago, IL |
| Residency: | University of Chicago Hospitals, General Surgery, Chicago, IL |
| Fellowship: | University of Chicago Hospitals, Transplantation Surgery, Chicago, IL |
| Other Education: | (Other) L' Institut d'Etudes Politiques de Paris, Paris, France 75006, France |
| Other Education: | (Undergraduate) Princeton University, Princeton, NJ |
Certifications
Specialty Interests
Biliary and pancreatic surgery, gastrointestinal surgery, general surgery, hepatitis B.C., hepatobiliary and pancreatic surgery, hepatobiliary surgery, Hepatocellular Carcinoma, immunosuppression, laparoscopic liver surgery, liver, liver and pancreas transplantation, liver transplantation, living donor liver transplantation, Liver surgery, living donor liver transplantation (duplicate), organ donation, pediatric liver transplant, recovery and preservation, surgical endoscopy, Portal Hypertension.
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 5/29/2009 the review process regarding Dr. Winans’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
